FI20075054A0 - Prell - uusi T-solujen säätelijä - Google Patents

Prell - uusi T-solujen säätelijä

Info

Publication number
FI20075054A0
FI20075054A0 FI20075054A FI20075054A FI20075054A0 FI 20075054 A0 FI20075054 A0 FI 20075054A0 FI 20075054 A FI20075054 A FI 20075054A FI 20075054 A FI20075054 A FI 20075054A FI 20075054 A0 FI20075054 A0 FI 20075054A0
Authority
FI
Finland
Prior art keywords
prell
cells
new regulator
regulator
new
Prior art date
Application number
FI20075054A
Other languages
English (en)
Swedish (sv)
Inventor
Riitta Lahesmaa
Johanna Tahvanainen
Original Assignee
Riitta Lahesmaa
Johanna Tahvanainen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riitta Lahesmaa, Johanna Tahvanainen filed Critical Riitta Lahesmaa
Priority to FI20075054A priority Critical patent/FI20075054A0/fi
Publication of FI20075054A0 publication Critical patent/FI20075054A0/fi
Priority to PCT/FI2008/050025 priority patent/WO2008090263A1/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/06—Methods of screening libraries by measuring effects on living organisms, tissues or cells
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • C40B40/08—Libraries containing RNA or DNA which encodes proteins, e.g. gene libraries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI20075054A 2007-01-26 2007-01-26 Prell - uusi T-solujen säätelijä FI20075054A0 (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20075054A FI20075054A0 (fi) 2007-01-26 2007-01-26 Prell - uusi T-solujen säätelijä
PCT/FI2008/050025 WO2008090263A1 (en) 2007-01-26 2008-01-28 Preli - a novel t-cell regulator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20075054A FI20075054A0 (fi) 2007-01-26 2007-01-26 Prell - uusi T-solujen säätelijä

Publications (1)

Publication Number Publication Date
FI20075054A0 true FI20075054A0 (fi) 2007-01-26

Family

ID=37745746

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20075054A FI20075054A0 (fi) 2007-01-26 2007-01-26 Prell - uusi T-solujen säätelijä

Country Status (2)

Country Link
FI (1) FI20075054A0 (fi)
WO (1) WO2008090263A1 (fi)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858712A (en) * 1997-02-06 1999-01-12 Incyte Pharmaceuticals, Inc. CDNA encoding a LEA-motif developmental protein homologous to avian px19
US7659077B2 (en) * 2003-03-17 2010-02-09 Riikka Lund Methods utilizing target genes related to immune-mediated diseases
WO2005019258A2 (en) * 2003-08-11 2005-03-03 Genentech, Inc. Compositions and methods for the treatment of immune related diseases

Also Published As

Publication number Publication date
WO2008090263A8 (en) 2009-07-30
WO2008090263A1 (en) 2008-07-31

Similar Documents

Publication Publication Date Title
DK2574677T3 (da) Fremgangsmåder til celledyrkning
DK2448963T3 (da) T-celle receptorer
BR112012014158A2 (pt) "célula eletroquímica"
BRPI0912297A2 (pt) células primárias de lítio
DK2344682T3 (da) Elektrode for elektrolysecelle
DE102008055028A8 (de) Solarzelle
SMAP201100036A (it) Reattore elettrochimico
DE602008000048D1 (de) Brennstoffzelle
DK2027150T3 (da) Allo-begrænsede peptid-specifikke t-celler
UY3776Q (es) Reloj pulsera
DE102008055036A8 (de) Solarzelle
FI20095645A (fi) Ohut paristo
BRPI0814572A2 (pt) Célula de lítio
BRPI0919559A2 (pt) baterias
IT1395037B1 (it) Cartuccia di umidificazione
DE502008001751D1 (de) Korrektor
BRPI0813726A2 (pt) Célula de lítio
BRPI0815981A2 (pt) reguladores metabólicos
BR112012001230A2 (pt) célula galvânica
FI20075054A0 (fi) Prell - uusi T-solujen säätelijä
FI20070650A0 (fi) Uusia solujen N-glykaaneja
UA17187S (uk) Календар
FI20085724A0 (fi) Soluviljely
CN300781486S (zh) 电池组
UA18692S (uk) Батарея